Eli Lilly Acquires ARMO BioSciences and AurKa Pharma Within a Week
By Natasha Piper
Pharma Deals Review: Vol 2018 Issue 5 (Table of Contents)
Published: 23 May-2018
DOI: 10.3833/pdr.v2018.i5.2326 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Eli Lilly has announced a definitive agreement to acquire ARMO BioSciences for US$50 per share, or approximately US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS